Clinical monitoring Resilience Care specializes in remote patient monitoring for oncology, gastroenterology, and psychiatry, offering a CE Class IIa medical device for clinician use and a patient mobile app. This presents sales opportunities to healthcare providers seeking scalable remote monitoring solutions and to CROs/academic partners needing robust data collection for clinical studies.

Large patient reach With 30,000 patients across 190+ facilities and involvement in more than 20 academic and industrial studies, there is potential to upsell to existing customers, expand into new specialties, or cross-sell additional modules and integrations to facilities already engaged with their platform.

Data powered The company focuses on harnessing data for healthcare and therapeutic innovation, indicating opportunities to position Resilience Care as a data infrastructure and analytics partner for personalized medicine initiatives, real-world evidence generation, and outcomes-based contracts.

Growth funding With substantial funding of 116M and a revenue range of 1M-10M, there is capacity for scale partnerships, co-development with larger health tech buyers, and fast-tracked pilots or regional expansions to accelerate adoption in new markets.

Global academic ties Active involvement in academic and industrial clinical studies suggests potential collaborations with universities and research organizations, offering opportunities to secure multi-site trials, data-sharing agreements, and grant-supported deployments.